Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of STSP-0902 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics, and immunogenicity of STSP-0902 in healthy subjects has completed. The trial was sponsored by S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthenozoospermia
• Oligozoospermia

Drugs mentioned

• STSP-0902

Snippet

Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd | Conditions: Oligozoospermia, Asthenozoospermia | Phase 1 | Status: COMPLETED